Possis Medical raises fresh funds:
This article was originally published in Clinica
Executive Summary
Cardiology developer Possis Medical has netted $23.6 million from the sale of 1.75 million shares for $14.50 each. Proceeds will be used to fund clinical trials, increase manufacturing capacity and expand marketing and sales activities, the company says.